Investment Rating - The report assigns a "Buy" rating to the company with a current price of HKD 7.34 and a fair value of HKD 10.77 [3]. Core Insights - The company achieved its 2025 performance targets, with a revenue of RMB 4.76 billion, representing a year-on-year growth of 24.1%, and a net profit attributable to shareholders of RMB 486 million, up 38.9% year-on-year [7]. - The company plans to continue its rapid store expansion, aiming for approximately 800 stores by the end of 2026, with a target growth rate of 30% for domestic stores [7]. - The company’s profitability is improving due to store type reforms and penetration into lower-tier cities, with a gross margin of 68.3% and a net profit margin of 10.2% for 2025 [7]. - A dividend of RMB 310 million is proposed, representing 63% of the net profit for 2025, with a dividend yield of 7.0% [7]. - The company forecasts revenue growth of over 20% and adjusted net profit growth of over 30% for the upcoming years [7]. Financial Projections - Revenue projections for 2024A to 2028E are as follows: RMB 3.84 billion (2024A), RMB 4.76 billion (2025A), RMB 5.95 billion (2026E), RMB 7.36 billion (2027E), and RMB 8.97 billion (2028E) [2]. - The expected growth rates for revenue are 6.9% (2024A), 24.1% (2025A), 25.0% (2026E), 23.7% (2027E), and 21.7% (2028E) [11]. - The projected net profit attributable to shareholders is RMB 350 million (2024A), RMB 486 million (2025A), RMB 638 million (2026E), RMB 826 million (2027E), and RMB 1.05 billion (2028E) [2]. Store Performance - The company opened a total of 144 new stores in 2025, with a net increase of 37 in the first half and 107 in the second half [7]. - Same-store sales showed a decline of 0.8% for the year, primarily due to a poor performance in Q1, but improved in subsequent quarters [7]. - The average daily sales per store decreased by 13% year-on-year, attributed to a reduction in store size [7]. Profitability Metrics - The company’s EBITDA for 2024A to 2028E is projected to be RMB 884 million (2024A), RMB 631 million (2025A), RMB 1.28 billion (2026E), RMB 1.51 billion (2027E), and RMB 1.79 billion (2028E) [2]. - The return on equity (ROE) is expected to be 45.4% (2024A), 27.8% (2025A), 31.8% (2026E), 35.3% (2027E), and 38.1% (2028E) [2].

Investment Rating - The report initiates coverage on the company with a "Buy" rating and sets a target price of HKD 66.90, indicating a potential upside of 37.65% from the current price of HKD 48.60 [4][6][7]. Core Insights - The company, Baiaosaitu (2315.HK), is a technology-driven biotechnology firm focused on gene editing and aims to become a global source of new drugs. Its core business revolves around two main lines: preclinical products and services, and antibody molecule transfer and development through the "Thousand Mice, Ten Thousand Antibodies" program [2][16]. - The preclinical business is experiencing robust growth, benefiting from the enthusiasm for innovative research. In the first half of 2025, the preclinical products and services generated revenue of CNY 458 million, with innovative model animal sales reaching CNY 274 million, a year-on-year increase of 56% [3][28]. - The "Thousand Mice, Ten Thousand Antibodies" business model, which includes upfront payments, milestone payments, and revenue sharing, is entering a harvest phase, with expectations for significant revenue growth as the number of transferred antibody projects increases [3][4]. Summary by Sections Company Analysis - Baiaosaitu is positioned as a leading biotechnology company with a focus on gene editing technology, offering preclinical pharmacology and efficacy evaluation services, innovative model animal sales, and gene editing services [2][16]. - The antibody development business leverages the "Thousand Mice, Ten Thousand Antibodies" initiative to create a library of antibodies, providing licensing services that are expected to drive future growth [2][3]. Preclinical Business Growth - The preclinical pharmacology and efficacy evaluation services are expanding rapidly, with revenue projected to grow significantly due to the increasing demand for innovative research tools and services [3][28]. - The sales of model animals, particularly humanized mouse models, are a major revenue source, with sales expected to grow from CNY 66 million in 2020 to CNY 389 million in 2024, reflecting a CAGR of 55.9% [17][28]. Antibody Development - The antibody development segment is projected to grow from CNY 41 million in 2020 to CNY 318 million in 2024, with a CAGR of 66.8%, driven by the RenMice technology platform and a vast antibody library [19][20]. - The company has established a strong foothold in the overseas market, with international revenue increasing from CNY 91 million in 2020 to CNY 662 million in 2024, representing a CAGR of 64.3% [27][28].

Investment Rating - The investment rating for China Overseas Hongyang Group (0081) is "Buy" [6]. Core Insights - In 2025, the company significantly increased its land acquisition intensity, strengthening its market share in strategic cities. Financially, the company maintained stability, optimized its asset structure, and reduced financing costs [2][3]. Financial Summary - **Revenue**: The total revenue for 2025 is projected at 36,874.44 million RMB, a decrease of 19.7% compared to 2024. The revenue from development business is 36,381 million RMB, while commercial property operation revenue is 493 million RMB [4][15]. - **Gross Profit**: The gross profit is expected to be 3,201 million RMB, with a gross margin of 8.7%, which is an increase of 0.3 percentage points year-on-year [4][15]. - **Net Profit**: The net profit attributable to shareholders is projected at 304.66 million RMB, down 68.1% from the previous year [4][15]. - **PE Ratio**: The price-to-earnings (PE) ratio for 2025 is 23.02 [4]. - **PB Ratio**: The price-to-book (PB) ratio is 0.22 for 2025 [4]. Sales Performance - **Sales Amount**: The sales amount for 2025 is expected to be 32,185 million RMB, a decline of 19.8% year-on-year. The average selling price is 10,955 RMB per square meter [17]. - **Market Position**: The company ranks in the top 3 in sales in 21 cities, with a top position in 7 cities, including Lanzhou, Yinchuan, Taizhou, and Jilin, where the market share exceeds 20% [17]. Land Acquisition and Investment - **Land Acquisition**: In 2025, the company added 22 new land parcels with a total floor area of 2,928,800 square meters, with a total land cost of 11.708 billion RMB. The total land reserve by the end of 2025 is 11,992,300 square meters, with an equity ratio of 85.5% across 33 cities [17][19]. Financial Structure and Costs - **Cash Flow**: The operating cash flow for 2025 is projected at 2.187 billion RMB, continuing a positive trend since 2022 [19]. - **Debt Ratio**: The debt-to-asset ratio is expected to decrease to 68.0% in 2025, down 2.9 percentage points from 2024 [19]. - **Financing Costs**: The weighted average financing cost is projected to be 3.4% in 2025, a decrease of 0.7 percentage points year-on-year [19].

Investment Rating - The report maintains a "Buy" rating for China Construction Industry (830 HK) with a target price of HKD 1.04 [5][7]. Core Insights - The company's FY25 net profit attributable to shareholders is expected to decline by 63.5% to HKD 240 million, significantly lower than the forecast of HKD 660 million, primarily due to fluctuations in the Hong Kong real estate market affecting its curtain wall engineering business and losses from projects in the UK and North America totaling HKD 260 million [1][5]. - Despite the challenges, the report highlights attractive prospects for the company, including potential rebounds in private residential construction in Hong Kong and significant business opportunities from the development of the Northern Metropolis, projected to generate HKD 50.6 billion in market opportunities [2][3]. Summary by Sections Financial Performance - For FY25, the company anticipates a revenue of HKD 5.975 billion, reflecting a 26.2% decrease from the previous year, with a net profit of HKD 237 million, down 63.5% [6][12]. - The gross profit margin is expected to decline to 7.6%, with a significant drop in operating profit margin to 5.4% [12][19]. Market Outlook - The report notes a substantial 55.8% year-on-year decline in the number of private residential construction starts in Hong Kong for 2025, attributed to developers slowing down project progress to mitigate financial impacts from market volatility [2]. - However, the potential supply of new private residential units is projected to stabilize, which may allow developers to resume some development activities [2]. Business Innovations - The BIPV (Building-Integrated Photovoltaics) segment has started contributing positively to profits, with a gross margin exceeding 10%, higher than the overall company gross margin [4]. - The company has expanded its presence in the Singapore market, securing various curtain wall engineering projects, including government contracts [4]. Long-term Growth Potential - The Northern Metropolis development has been incorporated into the national "14th Five-Year Plan," which is expected to create substantial business opportunities for the curtain wall market [3]. - The company has only secured HKD 330 million in contracts related to the Northern Metropolis, indicating significant room for growth in the medium to long term [3].

Investment Rating - The report assigns an IPO-specific score of 5.0, suggesting a cautious subscription approach for the company [10]. Core Insights - The company, Fourier, specializes in audio amplifier chips and haptic feedback chips, focusing on low-power and medium-to-high power audio chip design, with a notable improvement in gross margin [1][3]. - The Chinese audio amplifier chip market is projected to grow from 41 billion yuan in 2024 to 99 billion yuan by 2029, with a CAGR of 19.4%, indicating a robust growth outlook compared to the global market [2]. Company Overview - Fourier's core products include low-power audio chips, medium-to-high power audio chips, haptic feedback chips, and power management chips, with revenue projections of 130 million yuan in 2022, 150 million yuan in 2023, and 355 million yuan in 2024 [1]. - The company has experienced continuous net losses since its establishment, with net losses of 66 million yuan, 94 million yuan, 57 million yuan, and 52 million yuan for the years 2022, 2023, 2024, and the first ten months of 2025, respectively [4]. Industry Status and Outlook - The global audio amplifier chip market is expected to grow from 89 billion yuan in 2024 to 204 billion yuan by 2029, with a CAGR of 18.1%, highlighting significant growth potential [2]. - The Chinese market's growth rate surpasses the global average, indicating strong domestic demand for audio amplifier chips [2]. Advantages and Opportunities - Fourier has developed several first-of-their-kind products in China, including the first integrated ASIC DSP portable audio amplifier chip in 2017 and the first automotive-grade AEC-Q100 certified audio amplifier chip in 2023 [3]. - The company has secured 37.2 million yuan in intended orders from new energy vehicle manufacturers, with expected revenue recognition in 2026, and is exploring new applications in drones, intercoms, and panoramic cameras [3]. Financial Data and Use of Proceeds - The company plans to raise approximately 480 million HKD through its IPO, with 46.8% allocated for building a new R&D center to enhance audio amplifier chip development [7][9]. - Other allocations include 17.8% for purchasing automated testing equipment and 17.3% for industry mergers and strategic partnerships [7][9].

Investment Rating - The report maintains a "Buy" rating for China Resources Beer [5] Core Views - The company reported a revenue of 37.985 billion RMB in 2025, a decrease of 1.7% year-on-year, with a net profit attributable to shareholders of 3.371 billion RMB, down 28.9% year-on-year. However, if the impairment of goodwill related to liquor business of 2.877 billion RMB is added back, the net profit would be 6.248 billion RMB, reflecting a year-on-year increase of 31.8% [1] - The beer business showed stable growth, with revenue of 36.489 billion RMB in 2025, a slight increase of 0.01% year-on-year, and sales volume reaching 11.03 million kiloliters, up 1.43% year-on-year. The company continues to focus on high-end beer products, with sales of mid-to-high-end beers growing in the mid-single digits year-on-year, accounting for nearly 25% of total sales [1][2] - The liquor business faced significant challenges, with revenue of 1.496 billion RMB in 2025, down 30.39% year-on-year, primarily due to deep adjustments in the liquor industry and shrinking consumer demand. The company has recognized an impairment of 2.877 billion RMB for its liquor business [2] - The company is expected to benefit from the recovery of the dining sector and the upcoming World Cup, with projected net profits for 2026-2028 expected to grow by 42.9%, 15.9%, and 13.2% respectively, reaching 4.82 billion RMB, 5.58 billion RMB, and 6.32 billion RMB [3] Financial Summary - In 2025, the company achieved a gross margin of 43.1%, an increase of 0.5 percentage points year-on-year, driven by the ongoing high-end strategy. The EBITDA margin for the beer business reached 26.3%, up 3.9 percentage points year-on-year [2] - The projected financials for 2026-2028 indicate a gradual recovery, with revenues expected to grow from 38.948 billion RMB in 2026 to 40.861 billion RMB in 2028, and net profits expected to rise from 4.816 billion RMB to 6.319 billion RMB over the same period [4][9]

Investment Rating - The report maintains a "Buy" rating for China Construction Industry (830 HK) with a target price of HKD 1.04 [5][7]. Core Insights - The company's FY25 net profit attributable to shareholders is expected to decline by 63.5% to HKD 240 million, significantly lower than the forecast of HKD 660 million, primarily due to fluctuations in the Hong Kong real estate market affecting its curtain wall engineering business and losses from projects in the UK and North America totaling HKD 260 million [1][5]. - Despite the challenges, the company’s outlook remains attractive due to potential rebounds in private residential construction in Hong Kong and opportunities from the Northern Metropolis development plan, which is expected to generate HKD 50.6 billion in business opportunities for the curtain wall market [3][4]. Summary by Sections Financial Performance - FY25 revenue is projected to decline by 26.2% to HKD 5.975 billion, with a net profit of HKD 237 million, reflecting a 63.5% decrease [6][12]. - The company’s gross profit margin is expected to drop to 7.6%, while the operating profit margin is projected at 5.4% [12][19]. Market Trends - The private residential construction volume in Hong Kong is anticipated to rebound in the medium term, following a significant decline of 55.8% in 2025 [2]. - The potential supply of new private residential units is expected to decrease from 109,000 at the end of 2023 to 104,000 by the end of 2025, which may benefit developers in resuming some development activities [2][17]. Business Innovations - The BIPV (Building-Integrated Photovoltaics) segment has started contributing positively to profits, with a gross margin exceeding 10% in FY25, higher than the overall company gross margin [4]. - The company has expanded its presence in the Singapore market, securing various curtain wall engineering projects, including government contracts [4]. Long-term Opportunities - The Northern Metropolis development has been included in the national "14th Five-Year Plan," which is expected to create substantial business opportunities for the company [3]. - The company’s current bid amount for the Northern Metropolis is only HKD 330 million, indicating significant growth potential in the medium to long term [3].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 100.70 [7][16]. Core Insights - The company achieved its first quarterly profit in Q4 2025, with a revenue of RMB 223 billion, representing a 38% year-on-year increase and a net profit of RMB 3.8 billion, marking a turnaround from losses [1][2]. - The report highlights the company's strong performance driven by scale effects, improved high-margin services, and carbon credit contributions, projecting continued growth in 2026 due to its dual-energy vehicle product matrix and advancements in Robotaxi and AI driving capabilities [1][3]. Financial Performance - In Q4 2025, the company sold 116,000 new vehicles, a 27% year-on-year increase, with an overall gross margin of 21.3%, up 6.9 percentage points year-on-year [2][21]. - The report forecasts revenues of RMB 1,036 billion for 2026, RMB 1,305 billion for 2027, and RMB 1,678 billion for 2028, with a significant improvement in net profit expected [5][11]. Vehicle and Product Development - The company plans to launch four new models in 2026, including a flagship large SUV and three Robotaxi models, which are expected to enhance profitability and market presence [3][4]. - The introduction of the VLA 2.0 technology and self-developed Turing chips is anticipated to accelerate the commercialization of AI applications in vehicles and robots [4][5]. Valuation and Market Position - The report employs a segmented valuation approach, estimating the automotive sales business at 0.95x 2026E PS, with a total estimated market value of approximately RMB 1,693 billion [5][16]. - The Robotaxi business is valued at RMB 233 billion, while the humanoid robot business is estimated at RMB 360 billion, reflecting the company's competitive positioning in the market [5][15].

Investment Rating - The report assigns a cautious investment rating for the company, suggesting a careful subscription to the IPO due to its current financial state and market conditions [10]. Core Insights - The company, Fourier, specializes in audio amplifier chips and haptic feedback chips, focusing on low-power and medium-to-high power audio chip design, with a projected revenue growth from 130 million in 2022 to 355 million in 2024 [1]. - The Chinese audio amplifier chip market is expected to grow from 41 billion in 2024 to 99 billion by 2029, with a CAGR of 19.4%, indicating a robust growth potential compared to the global market [2]. - Fourier has several first-to-market products and a strong R&D team, which positions it well for future growth, particularly in the consumer electronics and smart automotive sectors [3]. Company Overview - Fourier's core products include low-power audio chips, medium-to-high power audio chips, haptic feedback chips, and power management chips [1]. - The company has faced continuous net losses since its establishment, with losses of 66 million, 94 million, 57 million, and 52 million from 2022 to the first ten months of 2025 [4]. - The company has received significant intent orders from new energy vehicle manufacturers, amounting to 37.2 million, which could confirm revenue by 2026 [3]. Financial Data - Revenue projections for Fourier are 130 million in 2022, 150 million in 2023, and 355 million in 2024, with 281 million reported for the first ten months of 2025 [1]. - The gross margin is showing signs of improvement, with a reported gross margin of 20.0% for the first ten months of 2025 [3]. IPO Information - The IPO is scheduled from March 23 to March 26, 2026, with a share price range of 40.0 to 50.0 HKD, leading to a market capitalization between 4.48 billion and 5.6 billion HKD [5]. - The net proceeds from the IPO are estimated at approximately 480 million HKD, with significant allocations for R&D and operational enhancements [7][9].

Investment Rating - The investment rating for China Overseas Macro Yang Group is maintained at "Buy" with a target price of HKD 2.51 [1][5] Core Views - The company reported a revenue of RMB 36.874 billion for 2025, a decrease of 20% year-on-year, and a net profit attributable to shareholders of RMB 305 million, down 68% year-on-year, slightly below the previous expectation of RMB 327 million [1][2] - Despite the decline in revenue and profit, the company has projects located in core areas of lower-tier cities, which can help maintain sales velocity and profit margins. The expectation is that as high-margin projects are gradually recognized, the company's performance may improve [1][2] - The company has seen a significant increase in land acquisition, with a total land acquisition amount of RMB 11.7 billion, up 124% year-on-year, indicating a strong investment intensity [3][4] Summary by Sections Financial Performance - The gross profit margin slightly improved, with the net profit margin decreasing by 1.25 percentage points to 0.83% [2] - The company’s debt ratios have improved, with the asset-liability ratio decreasing by 1.6 percentage points to 61.4% and the net debt ratio down by 1.4 percentage points to 31.7% [4] Sales and Marketing - The company’s equity sales amount to RMB 28 billion, down 18% year-on-year, which is a larger decline than the national average of 13% [3] - The sales expense ratio increased by 0.5 percentage points to 3.5% as the company intensified marketing efforts to promote sales [2] Future Outlook - The company’s new projects from 2022 to 2025 have a total value of RMB 92.9 billion, with an expected average gross profit margin of 19%, significantly higher than the reported gross profit margin for 2024-2025 [2] - The forecast for net profit attributable to shareholders for 2026 and 2027 has been revised down by 34% and 47% to RMB 289 million and RMB 304 million, respectively, with an expected EPS of RMB 0.08 and RMB 0.09 [5][14]